Recombinant Human GLRA3 Protein (Baculovirus)，Strep

GLRA3, or Glycine Receptor Alpha-3, is a subunit of the inhibitory glycine receptor primarily found in the central nervous system, where it plays a crucial role in neurotransmission and the modulation of motor and sensory pathways. The receptor functions through the binding of glycine, leading to chloride ion influx and subsequent hyperpolarization of neurons. Abnormalities in GLRA3 expression or function have been implicated in various neurological disorders, including hyperekplexia, a condition characterized by exaggerated startle responses. The study of GLRA3 recombinant proteins has gained traction due to their potential therapeutic implications and their utility in deciphering the receptor's structure-function relationship. By generating and characterizing GLRA3 recombinant proteins, researchers aim to investigate the receptor's binding mechanisms, ion conductance properties, and interactions with various pharmacological agents. Furthermore, these studies could shed light on how mutations in GLRA3 contribute to disease manifestations. Understanding the detailed biochemistry of GLRA3 via recombinant protein studies not only enhances our knowledge of glycine receptor physiology but also aids in the development of targeted therapies for related neurological disorders. Through techniques such as crystallography, electrophysiology, and ligand-binding assays, scientists can obtain essential insights into the receptor's functional dynamics, ultimately contributing to advancements in neuropharmacology and therapeutic interventions.